Subsequent Malignant Neoplasms in Retinoblastoma Survivors

Research output: Contribution to journalReview articleAcademicpeer-review

7 Citations (Scopus)

Abstract

Retinoblastoma (Rb) is a pediatric malignant eye tumor. Subsequent malignant neoplasms (SMNs) and trilateral Rb (TRb) are the leading cause of death in heritable Rb patients in developed countries. The high rate of SMNs in heritable Rb patients is attributed to the presence of a mutation in the RB1 tumor suppressor gene. In addition, Rb therapy choices also influence SMN incidence in this patient group. The incidence rates and age of occurrence for the most frequent SMNs and TRb will be discussed. In addition, the impact of genetic predisposition and Rb treatments on the development of SMNs will be evaluated. Furthermore, screening and other prevention methods will be reviewed.

Original languageEnglish
Article number1200
Pages (from-to)1-18
Number of pages18
JournalCancers
Volume13
Issue number6
DOIs
Publication statusPublished - 2 Mar 2021

Keywords

  • Heritable Rb
  • Long‐term surveillance
  • Retinoblastoma
  • Second primary malignancies
  • Subsequent malignant neoplasms
  • Trilateral Rb

Cite this